Associate Dean for Research Innovation, Professor, Pharmaceutical Sciences
University of Pittsburgh
Dr Xiang-Qun (Sean) Xie is an Associate Dean for Research Innovation at School of Pharmacy and a Professor of Pharmaceutical Sciences/Drug Discovery Institute, and a PI of an integrated Medicinal Chemistry Biology laboratory of CompuGroup, BioGroup and ChemGroup (www.CBLigand.org/XieLab) at University of Pittsburgh. He is a member of the Science Advisory Board to the US FDA. He is a Founding Director of Computational Chemical Genomics Screening Center (www.CBLigand.org/CCGS), and a Director/PI of NIH National Center of Excellence for CDAR (www.CDARCenter.org). He holds joint positions at Dept of Computational Biology and Dept of Structural Biology, and Pitt Cancer Institute MT/DD Program. He is an Editorial Advisory Board member for AAPS Journal and American Journal of Molecular Biology, and Associate Editor of BMC Pharmacology Toxicology.
Committee of Biotechnologies and VirusSphere, WABT
Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). His researches have been concerned with the characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Edith Cowan University
Ian James Martins is a reviewer for various journals and was appointed as the Chief Editor for Scientific and Academic Publishing (2013/2014). Research Gate’s analysis of Dr Martins publication stats places the RG score higher than 93% of the international researchers. Dr Martins is a Fellow at Edith Cowan University/Honorary Senior Fellow (University Western Australia).
Mississippi State University
C P Coyne has completed his DVM at Colorado State University at Fort Collins Colorado, followed by an Internship in Surgery, PhD (Radiopharmacology) and Residency in Internal Medicine at the University of California at Davis. Currently he is a Professor of Molecular Pharmacology and Immunology in the Department of Basic Sciences, College of Veterinary Medicine at Mississippi State University. He has published over 50 peer-reviewed manuscripts in addition to the first comprehensive text on Diagnostic Pharmacology. Majority of recent and current on-going research investigations are devoted to the design of the molecular structure and organic chemistry reactions for the synthesis of biopharmaceuticals that have properties of selective targeted delivery and anti-neoplastic cytotoxicity.
Omer Halisdemir University